Stocks to buy

Investing in business development companies (BDCs) can yield high income due to their tax structure and dividend distribution requirements. They raise funds through equity sales and competitively priced debt to invest in business debt and preferred equity. BDCs can secure favorable investment terms by providing substantial capital to businesses that lack access to traditional financing.
0 Comments
Investors may want to keep an eye on the biotech boom and these top biotech stocks to watch. For one, the sector is still one of the safest, most recession-proof investments around. Two, an aging population is demanding better treatment in an effort to live longer lives. Three, there’s the incredible new innovation in gene therapies, immuno-oncology,
0 Comments
Meme stocks are a contentious topic.  Many traditional investors criticizing the lack of solid business fundamentals for supporting previous rapid increases in stock prices.  Others suggest that companies with a speculative nature should see rapid movements. It’s all part of the investing game, and if short-sellers get caught flat-footed, so be it. The past two
0 Comments
When it comes to investing for the long-haul, blue-chip stocks may first come to mind. However, alongside these venerable, steady names, adding a few of the best stocks to buy for long-term growth may be another profitable decision to make. The emphasis here, of course, is on “long-term,” rather than merely “growth.” There are plenty
0 Comments
While the concept of acquiring low-PE ratio blue-chip stocks (that is, industry-leading stalwarts that feature low price-earnings ratios relative to their sectors) appeals on paper, investors need to be cautious. You can’t just buy companies based on any one single metric. In addition, sometimes a very cheap PE can actually signal significant fundamental problems. Instead,
0 Comments
Fundamentally, the driving catalyst for biotech stocks to buy centers on the possibility of supporting paradigm-shifting medical breakthroughs. For example, a report published by the JAMA Network indicates that experts project the global economic cost of cancers from 2020 to 2050 will be $25.2 trillion (in constant 2017 dollar terms). Therefore, finding a cure would
0 Comments
Without question, tech has been the best-performing group so far in 2023. Understandably, that’s got investors looking at the best tech stocks to buy.  At the same time though, that does create a tough situation. On the one hand, investors want to stick with what’s working. The mentality of “The trend is your friend” has
0 Comments
Welcome to another week of Hypergrowth Investing, folks! With earnings season underway, we’re laser-focused on companies’ first-quarter results and what that means for stocks going forward. As we’ve mentioned previously, in the first three months of this year, both the labor market and consumer spending were quite resilient. And those two factors should support strong
0 Comments
There are multiple signs that inflation is rolling over, while consumer spending remains strong and corporate earnings are beating expectations. Meanwhile, the so-called credit crunch many investors have feared really isn’t materializing. Thus, right now may be an excellent time for investors to find high-quality stocks to buy. On the inflation front, the Producer Price
0 Comments
Just about everything is cyclical. That’s true of the market and growth stocks in particular. Growth stocks thrive in low-interest environments.  Such an environment existed from the period following the great financial crisis all the way up to early 2022. Keeping interest rates close to zero resulted in strong growth stock performance.  Runaway inflation forced
0 Comments